Insider buying last 90 days
No open-market insider purchases were filed for MRX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every MRX insider filing, plotted on the chart in Gekko.Open MRX in Gekko
Gekko Brief
AI summaryMarex issued two fixed-income Eurobonds totaling US$1 million this week, a modest financing move that management expects to support acquisitions, trading and clearing activity, and balance sheet flexibility. The news carries a positive sentiment reading and touches on the company's liability structure rather than its operating results.
Marex closes at $71.29, above both its 50-day average of $69.49 and its 200-day average of $53.33, with the shorter average sitting above the longer one, a configuration generally read as supportive of the existing trend. The GekkoIndex reads 57.9, placing the stock in the Neutral zone, up 6.3 over the last five readings. Price sits 3% below Gekko Fair Value of $73.51, keeping it within 5% of that mark.
No confirmed earnings date is currently on the calendar, following a last report on 3 March 2026 that beat estimates ($1.13 versus $0.93 expected) but still produced a -8.8% reaction, part of a record full-year 2025 showing revenue near $2.0 billion. No insider, Congress or unusual options activity appears in the current windows, and seasonality data is insufficient for a read. Analyst coverage remains uniformly positive, with all 6 firms rating the stock a buy and a consensus target of $79.88, implying 12% upside from current levels.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Marex price vs fair value
Close $71.29200-day averageGekko Fair Value $73.51
Marex quick facts
- Market cap
- $5.13B
- P/E ratio
- 14.5
- Forward P/E
- 7.2
- EPS, TTM
- $5.00
- Revenue, TTM
- $3.49B
- Profit margin
- 12.2%
- Dividend yield
- 1.05%
- Beta
- -0.08
- Volume
- 581,116 avg 743,076
- 1-year return
- +111.2%
- Typical daily move
- ±4.5%
- Typical 20-day move
- ±8.3%
- 50-day average
- $69.49
- 200-day average
- $53.33
- Next earnings
- —
- Shares outstanding
- 71.93M
Marex swing-trade checklist
Marex scores 1 supportive, 2 mixed and 0 headwinds across the 3 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
1 supportive2 mixed0 headwinds
- Trendsupportive
Above 50 and 200-day
Close $71.29 is above the 50-day ($69.49) and 200-day ($53.33) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
57.9, Neutral
Reading 57.9 is in the Neutral zone.
See the GekkoIndex - Fair valuemixed
3.0% below
Price is within 5% of Gekko Fair Value (3% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskno data
No data
No confirmed report date on the calendar.
See earnings - Seasonalityno data
No data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Marex stock chart and price history
Marex closed at $71.29 on Sep 28, 2026, +111.2% over the past year, inside a 52-week range of $27.91 to $79.11.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −0.1%
- 3 months
- +21.0%
- 6 months
- +65.9%
- 1 year
- +111.2%
The full MRX chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open MRX in Gekko
Follow Marex through every session
Put MRX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track MRX in GekkoFree for 7 days. No credit card required.
Marex GekkoIndex: the smart money zone
Marex’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57.9, in the Neutral zone, up 6.3 points over five sessions.
57.9Neutral
Up 6.3 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 17 | +3.1% | +15.8% | ||
| Accumulation | 143 | +1.4% | +4.6% | ||
| Neutral (current zone) | 374 | +1.1% | +5.2% | ||
| Distribution | 67 | +1.6% | +4.3% | ||
| Selling | 1 | Too few readings yet | |||
Average MRX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the MRX price, zone by zone.Track MRX in Gekko
Is Marex stock overvalued? Gekko Fair Value
Marex trades 3.0% below Gekko Fair Value of $73.51, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Marex shares are worth, recalculated every trading day.
$73.51
Gekko Fair Value, Sep 26, 2026
3.0% below fair value · About fair value
Gekko Fair Value on every chart, with the gap to price updating daily.Open MRX in Gekko
Marex insider and Congress trading
No open-market insider purchases were filed for Marex, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in MRX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for MRX, plotted on the chart in Gekko.Open MRX in Gekko
Buybacks
Marex has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $125.6M
- As a share of market cap
- 2.45%
From company filings.
Hedge funds and billionaires quarter ended Sep 30
0of the funds Gekko tracks hold MRX.
0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Marex earnings: next date and track record
Marex beat the EPS estimate in 7 of its last 8 reports, moving 6.5% on average across the report.
7 of 8reports beat the EPS estimate
±6.5%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Mar 3, 2026 AI summary
- What they said
- Marex Group plc reported record full-year 2025 financial results with strong, broad-based growth across all segments. Full-year revenue rose to just over $2.0 billion (up 27% year over year) and adjusted profit before tax increased 30% to $418 million; Q4 was the strongest quarter with revenue up 38% to $572 million and adjusted PBT up 41% to $115 million. Management highlighted sevenfold profitability improvement since 2020, expanding client scale particularly among $5M+ clients, geographic expansion (notably the U.S., Middle East, Latin America, and Asia), and a mix of organic growth (~75%) and targeted M&A (~25%). Key strategic focus areas include Clearing, Agency & Execution (notably Prime), Market Making & Hedging, Investment Solutions, and digital initiatives (digital prime brokerage, accepting digital assets as collateral, licensing to convert crypto/fiat). Management emphasized high-quality, stable earnings (high Sharpe ratio, low daily variability), continued investment to support growth, ongoing M&A (WebTraders acquisition cited), and readiness to support tokenized assets and 24/7 margining where appropriate. In Q&A, management was confident but measured: they acknowledged near-term headwinds from elevated commodity volatility, potential impacts from geopolitical risk (Middle East), and uncertainty around the exact timing/magnitude of market moves, while reiterating confidence in delivering growth for 2026 within previously signaled corridors.
- Guidance
- Qualitative forward guidance: Management reiterated confidence in delivering growth for 2026 consistent with prior guidance/corridor (no new numeric guidance provided). They expect continued growth across all business lines (Clearing, Agency/Execution/Prime, Market Making, Hedging & Investment Solutions) and anticipate Solutions continuing to grow in line with the firm. Prime Services client addition rate ~30% annually (gross) with ~5% attrition was disclosed as an operating cadence expectation. Management signaled continued M&A activity (targeting geographic expansion in Asia and Latin America, and product/capability acquisitions), and noted an expectation to progress their digital/licensing efforts (crypto/fiat conversion license expected within weeks).
- Risks flagged
- Risks and headwinds discussed: elevated and episodic commodity market volatility increasing margin requirements and client liquidity pressure; potential short- and medium-term disruption from geopolitical conflict in the Middle East; macro/market uncertainty affecting client hedging behaviors and volumes; integration and execution risk associated with ongoing M&A; regulatory/licensing uncertainty around digital assets and tokenization (although management has applied for a license to convert crypto/fiat). The press release and prepared remarks reference forward-looking statement risks generally.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Mar 3, 2026 | $1.13 est $0.93 | $500.1M est $470.3M | −8.8% |
| Nov 6, 2025 | $0.92 est $0.96 | — | +9.5% |
| Aug 13, 2025 | $1.02 est $0.93 | — | +3.9% |
| May 15, 2025 | $0.91 est $0.89 | $2.15B est $455.2M | −5.9% |
| Mar 6, 2025 | $0.76 est $0.61 | — | +0.4% |
| Nov 7, 2024 | $0.76 est $0.68 | $740.0M est $377.0M | +2.0% |
| Aug 14, 2024 | $0.90 est $0.56 | — | +14.8% |
| May 29, 2024 | $0.70 est $0.68 | $720.7M | −6.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Marex stock forecast and analyst price targets
Analysts’ average 12-month price target for Marex is $79.88, +12.0% from the last close, from 6 firms rating the stock in the last 90 days.
$79.88consensus 12-month target, +12.0% from the last close
Now $71.29Avg $79.88
Low $75High $90
Each firm’s latest rating in the last 90 days: 6 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 4 | William O'Neil | — | — |
| Aug 13 | UBS | $90 | +26.2% |
| Aug 13 | Barclays | $86 | +20.6% |
| Aug 13 | KBW | $90 | +26.2% |
| Aug 10 | Barclays | $76 | +6.6% |
+5.2%average 20-day move after past Neutral readings
±4.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Marex market cap and key statistics
Marex’s market cap is $5.13B, with a P/E ratio of 14.5 and revenue of $3.49B over the last twelve months.
Valuation
- Market cap
- $5.13B
- P/E ratio
- 14.5
- Forward P/E
- 7.2
- EPS, TTM
- $5.00
- Gekko Fair Value
- $73.51
Trading
- Volume
- 581,116
- Avg volume, 20 days
- 743,076
- 52-week high
- $79.11
- 52-week low
- $27.91
- Shares outstanding
- 71.93M
Financials
- Revenue, TTM
- $3.49B
- Profit margin
- 12.2%
- Return on equity
- 26.2%
- Quarterly earnings growth, YoY
- +105.3%
Risk and income
- Beta
- -0.08
- Typical daily move
- ±4.5%
- Typical 20-day move
- ±8.3%
- Dividend yield
- 1.05%
Marex stock news this week
1 headline about Marex from the past week, newest first, each linking to the publisher.
- Will Foreign Investor Flows Change Marex Group's (MRX) NarrativeSimply Wall Street, Sep 28
Marex peers
Marex’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| GOOGLAlphabet | Neutral | 7.1% above |
| GOOGAlphabet | Neutral | 7.4% above |
| METAMeta Platforms | Neutral | 22.3% above |
| NFLXNetflix | Accumulation | 28.2% below |
| SPOTSpotify Technology | Accumulation | 10.3% above |
| MSTRStrategy | Neutral | 3.3% below |
A peer links to its own page where one exists.
Marex stock FAQ
What is Marex’s market cap?
Marex’s market cap is $5.13B at the Sep 28, 2026 close of $71.29, with 71.93M shares outstanding. The shares trade on a P/E ratio of 14.5.
What is the Marex stock forecast?
The consensus analyst 12-month price target for Marex is $79.88, +12.0% from the last close. Of the 6 firms that rated the stock in the last 90 days, 6 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Marex stock overvalued or undervalued?
On Gekko’s estimate Marex is about fair value: the Sep 28, 2026 close of $71.29 is 3.0% below Gekko Fair Value of $73.51. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
What is Marex’s 52-week high and low?
Marex’s 52-week high is $79.11 and its 52-week low is $27.91; it closed at $71.29 on Sep 28, 2026, +111.2% over the past year.
Is Marex stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 1 of the 3 items with data read as supportive (trend), 2 as mixed (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Marex the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.